Pharma critics censored?

Rumors of censorship swirl as Harvard's student-run health policy journal takes down its Web site

Brendan Borrell
Oct 20, 2008
If you visited the Web site of the student-run Harvard Health Policy Review last week, you would be greeted with the words "Access forbidden!" On Monday, rumors soon began circulating on the pharmaceutical blogs Pharmagossip and Gooznews that a higher authority had pulled the plug on access after the journal published a scathing attack in September on three Harvard professors who edit the Journal of Health Economics and serve as faculty advisors to the Review. Not true, Review editor-in-chief Kevin Huang told The Scientist. While the dispute led one Harvard economist, Richard Frank, to resign from the journal's advisory board, the decision to temporarily take the Web site down was made by student editors. "When the article broke," says Huang, "I really had no idea what was going on." The article had been handled by a senior editor, and he wanted read it and discuss it with the...
Review"Ethical Standards for Healthcare Journal Editors: A Case Report and Recommendations,"Donald LightRebecca WarburtonJournal of Health EconomicsJHEJoseph DiMasiJHEJHEThe ScientistJHEThomas McGuireThe ScientistJHEJHEReviewThe ScientistReviewmail@the-scientist.comCorrection (October 22): In the original version of this story, we incorrectly referred to Merrill Goozner's blog as Goozner News. The blog's true name is Gooznews. The Scientist regrets the error.

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?